You are here

P&T News

May 14

Averts Disease Worsening, Reduces Potential for Blindness
Risk May Remain for 6 Months After Treatment
FDA Removes Boxed Warning With Drug’s Fifth Approval
Overeager Use of Recommendations Creates Problems

May 9

Artificial Intelligence Enables Platform to Detect Amyloid PET Status
Kadcyla Cut Risk of Recurring Disease by Half Compared to Herceptin
May Lead to Personalized Treatment for Schizophrenia, Other Illnesses

May 7

Rare Disorder Typically Co-occurs With Cancer
First Medicines for Adults With Wild-type or Hereditary ATTR-CM
New Technique Could Benefit Patients With End-stage Lung Disease
Inhaled Form of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)

May 2

Global Incidence of Mosquito-Borne Disease Has Increased
FDA Gives Priority Regulatory Review of Diagnostic for Fast-Progressing Kidney Disease
Scrotal Ultrasound and Obtaining Serum Tumor Markers Among 45 Recommendations
Mavyret Now Approved for Adults and Children Over 12
Vaccine Can Prevent Painful Rash That Could Cause Vision Loss

April 30

Study Safety Data Support Early Treatment of Underlying Cause of CF
Phase 3 Study Confirmed Drug’s Comparable Safety and Efficacy
Axonal Fusion Process Could Someday Translate to Humans
Rare, Life-threatening Disease Has No Approved Treatment

April 25

Superior to Quinine in Reducing Mortality in Two Clinical Trials
Minimally Invasive Method Reduces Regurgitation and Leaking
Neurofilament Light Protein Correlated With Accumulated Brain Damage
Technology Designed to Improve Patient Care, Limit Infections

April 23

Medical Device Enables Nerve Stimulation During Sleep
May Offer Improved Safety Profile for Pediatric Patients
Hope for Sufferers With Post-Treatment Lyme Disease Syndrome
KardiaMobile Receives Two More Clearances for Arrhythmia Detection

April 18

Possible First Treatment Option for Rare Autoimmune Disease of the CNS